{"nct_id":"NCT05298423","title":"Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-05-03","start_date_type":"ACTUAL","primary_completion_date":"2026-08-19","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08-19","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}